Europe Plasma Fractionation Market Segmentation and Forecast by 2028 Growth, Size, Share, Trends


The plasma fractionation market in Europe is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Increasing geriatric population, increasing use of immunoglobulins in various therapeutic areas such as neurology, hematology, rare genetic disorders and autoimmune disorders along with growing demand for plasma derived therapies for management of diseases are all expected to boost plasma fractionation market in rest of Europe. Furthermore, various companies in Europe are investing more on research and development activities to develop and launch novel approaches in plasma therapies for management of diseases.     

Overview: Europe Plasma Fractionation Market

The Europe Plasma Fractionation Market encompasses key regional players including Germany, France, the UK, Spain, Italy, and other countries in the rest of Europe. As a major contributor to the global plasma fractionation industry, Europe is poised for strong market growth throughout the forecast period. Several factors are driving this expansion, such as an aging population, the growing use of immunoglobulins for chronic disease treatment, increasing prevalence of immune and bleeding disorders, and the rising application of plasma therapies for disease management.

Recent changes in medical practices across Europe, particularly in the treatment of chronic conditions such as neurological, hematological, and respiratory disorders, have also influenced the market. The COVID-19 pandemic shifted healthcare priorities, leading to disruptions in the diagnosis and management of several diseases. However, the crisis also brought attention to the potential of plasma therapy. Various organizations in Europe accelerated research into COVID-19, and several health authorities advocated for plasma-based treatments. For example, France’s National Agency for Medicines and Health Products Safety (ANSM) supported the use of immune plasma therapy for critically ill patients, while the European Commission recommended convalescent plasma for emergency use. These developments have had a mixed impact—boosting demand for plasma therapies during the pandemic, while temporarily diverting focus from other therapeutic areas.

Strategic Insights: Europe Plasma Fractionation Market

Strategic insights into the Europe Plasma Fractionation Market offer a comprehensive, data-driven analysis of the competitive landscape, current trends, and country-specific dynamics. These insights provide stakeholders—including investors, manufacturers, and healthcare providers—with actionable recommendations to enhance their market positioning. By identifying emerging opportunities, underserved segments, and potential areas for innovation, businesses can develop unique value propositions to differentiate themselves. Leveraging market analytics enables stakeholders to anticipate industry shifts and align their strategies for long-term success in this evolving sector.

Regional Insights: Tailoring Strategies Across Europe

Understanding the regional characteristics of the Europe Plasma Fractionation Market is vital for effective market penetration and growth. Differences in consumer preferences, economic environments, and healthcare regulations across countries require tailored approaches. For instance, product demands may vary by region due to differing clinical needs or local healthcare infrastructure. By recognizing these distinctions, companies can better allocate resources, create targeted marketing strategies, and adapt their offerings to meet local demands. This localized approach enhances competitiveness and opens pathways for expansion in underdeveloped markets across the region.

Europe Plasma Fractionation Market Segmentation

Europe Plasma Fractionation Market -By Product

  • Immunoglobulin
    • Intravenous Immunoglobulin (IVIG)
    • Subcutaneous Immunoglobulin (SCIG)
  • Albumin
  • Coagulation Factor Concentrates
  • Protease Inhibitors
  • Other

Europe Plasma Fractionation Market - BybApplication

  • Neurology
  • Immunology
  • Hematology
  • Critical Care
  • Pulmonology
  • Others

Europe Plasma Fractionation Market - By End User

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Europe Plasma Fractionation Market - By Country

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Europe Plasma Fractionation Market - Company Profiles

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma AG
  • Sanquin
  • SK Plasma

Other Reports:

North America Medical Marijuana Market: https://business-news-insights.blogspot.com/2025/05/north-america-medical-marijuana-market.html 

North America Wound Care Market: https://sites.google.com/view/wound-care-market-n/home 

North America Time-of-Flight Sensor Market: https://penzu.com/p/f65bbaf2c60df453 

North America Small Satellite Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/36 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Post a Comment

Popular posts from this blog

North America Small Satellite Market Current Status by 2028 Top Players

Image
The  North America small satellite market  is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Rising Support for Small Satellite Development In North America, both government entities and private companies are increasingly investing in the small satellite market, driven by growing demand across diverse applications such as Earth observation, communications, navigation, and scientific research. For example, in November 2021, Fleet Space Technologies secured US$26 million in funding to enhance its nanosatellite IoT connectivity network. Such initiatives reflect the strong governmental and private sector backing that is fueling the North America small satellite market growth. Small satellites play a critical role in national security, disaster response (e.g., monitoring earthquake or flood-affected regions), maritime surveillance, and support for communication, navigation, and resear...
Read more

North America Small Satellite Market Trends, Opportunity and Forecast 2022 to 2028

Image
The  North America Small Satellite Market  is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Growing Support for Small Satellite Development Governments and companies across North America are increasingly investing in the small satellite market to meet the growing demand for applications such as Earth observation, communication, navigation, and scientific research. In November 2021, Fleet Space Technologies secured $26 million in funding to expand its nanosatellite IoT connectivity fleet. Such investments from both public and private sectors are fueling market growth. Small satellites play a crucial role in enhancing national security, monitoring disaster-affected areas, tracking suspicious maritime activities, and supporting communication and scientific research. To further boost the industry, governments are promoting initiatives for rapid construction and domestic production o...
Read more

North America Small Satellite Market Latest Innovations, Top Players Forecast 2028

Image
The North America small satellite market is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Growing Support for Small Satellite Development Government agencies and private companies across North America are increasingly investing in the small satellite market, driven by the growing demand for their use in applications such as Earth observation, communication and navigation, and scientific research. For example, in November 2021, Fleet Space Technologies secured US$26 million to expand its nanosatellite IoT connectivity fleet. These kinds of investments from both public and private sectors are significantly contributing to the  market’s expansion . Small satellites enable government authorities to perform a wide range of critical functions, including maintaining national security, monitoring natural disaster zones, tracking suspicious maritime activities, and supporting communicati...
Read more